SevenBridge Financial Group LLC Has $3.70 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

SevenBridge Financial Group LLC lifted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 2.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 7,029 shares of the healthcare conglomerate’s stock after acquiring an additional 141 shares during the period. SevenBridge Financial Group LLC’s holdings in UnitedHealth Group were worth $3,700,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in UNH. Keebeck Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 11.6% in the second quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock valued at $5,185,000 after purchasing an additional 1,122 shares in the last quarter. Ascension Capital Advisors Inc. purchased a new stake in UnitedHealth Group in the 3rd quarter worth about $216,000. Physician Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group in the 3rd quarter valued at about $207,000. Bellecapital International Ltd. boosted its holdings in shares of UnitedHealth Group by 1.4% during the fourth quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after purchasing an additional 193 shares during the period. Finally, Bartlett & Co. LLC increased its stake in UnitedHealth Group by 5.7% in the 3rd quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock valued at $82,865,000 after buying an additional 8,873 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have commented on UNH. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 target price on shares of UnitedHealth Group in a research note on Friday, January 19th. Royal Bank of Canada reaffirmed an “outperform” rating and set a $596.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 29th. HSBC restated a “reduce” rating and set a $480.00 price target (down previously from $550.00) on shares of UnitedHealth Group in a research note on Monday, December 18th. Oppenheimer reiterated an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Finally, Bank of America reiterated a “buy” rating and set a $675.00 price target on shares of UnitedHealth Group in a research note on Thursday, March 7th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Get Our Latest Analysis on UNH

UnitedHealth Group Stock Down 0.4 %

Shares of UNH opened at $492.76 on Monday. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The firm has a market capitalization of $454.29 billion, a P/E ratio of 20.75, a P/E/G ratio of 1.35 and a beta of 0.54. The company has a 50-day simple moving average of $502.51 and a 200-day simple moving average of $518.82. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The business had revenue of $94.43 billion during the quarter, compared to analyst estimates of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. UnitedHealth Group’s revenue was up 14.1% on a year-over-year basis. During the same period in the prior year, the company posted $5.34 earnings per share. On average, equities research analysts expect that UnitedHealth Group Incorporated will post 27.82 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 31.54%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.